NiallMercerHeneyMDBao

PubMed

• 26 citations
  Incidence, Clinicopathological Risk Factors, Management and Outcomes of Nonmuscle Invasive Recurrence after Complete Response to Trimodality Therapy for Muscle Invasiv...
  Alejandro Sanchez, Matthew F. Wszolek, Andrzej Niemierko, R.H. Clayman, Michael Drumm, Dayron Rodriguez, Adam S. Feldman, Douglas M. Dahl, Niall M. Heney, William U. S...> ;The Journal of Urology. 2018 Feb 1
• 43 citations
  Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy
  Ross Krasnow, Michael Drumm, H.J. Roberts, Andrzej Niemierko, Chin-Lee Wu, Shulin Wu, Jing Zhang, Niall M. Heney, Matthew F. Wszolek, Michael L. Blute, Adam S. Feldman...> ;European Urology. 2017 Jul 1
• 215 citations
  Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hos...
  Nicholas J. Giacalone, William U. Shipley, R.H. Clayman, Andrzej Niemierko, Michael Drumm, Niall M. Heney, M.D. Michaelson, Richard T. Lee, Philip J. Saylor, Matthew F...> ;European Urology. 2017 Jun 1
• 417 citations
  Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
  William U. Shipley, W. Seiferheld, H. Lukka, Pierre Major, Niall M. Heney, David J. Grignon, Oliver Sartor, Maltibehn P. Patel, Jean Paul Bahary, Anthony L. Zietman, T...> ;The New England Journal of Medicine. 2017 Feb 1
• 14 citations
  Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.
  Raymond H. Mak, Daniel Hunt, Jason A. Efstathiou, Niall M. Heney, Christopher U. Jones, Himu Lukka, Jean-Paul Bahary, Malti Patel, Alexander Balogh, Abdenour Nabid, Ma...> ;Urologic Oncology. 2016 Oct 1
• 31 citations
  Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-...
  Timur Mitin, Asha George, Anthony L. Zietman, Niall M. Heney, Donald S. Kaufman, Robert G. Uzzo, Robert Dreicer, H. James Wallace, Luis Souhami, M. Chris Dobelbower, H...> ;International Journal of Radiation Oncology, Biology, Physics. 2014 Sep 1
• 7 citations
  Long-Term Outcomes of Organ Preservation in Patients with Small Cell Carcinoma of the Bladder
  Jairam R. Eswara, Niall M. Heney, Chin-Lee Wu, W. Scott McDougal> ;Urologia Internationalis. 2015 Jan 30
• 266 citations
  Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy...
  Raymond H. Mak, Daniel P. Hunt, William U. Shipley, Jason A. Efstathiou, William Tester, Michael P. Hagan, Donald S. Kaufman, Niall M. Heney, Anthony L. Zietman> ;Journal of Clinical Oncology. 2014 Dec 1
• 24 citations
  Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases
  Esther Oliva, Nathanael Pinheiro, Niall M. Heney, Donald S. Kaufman, William U. Shipley, Carol Gurski, Beverly Spicer, Gladell P. Paner, Allen M. Gown, Mahul B. Amin> ;Human Pathology. 2013 May 1
• 21 citations
  Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
  John J. Coen, Jonathan J. Paly, Andrzej Niemierko, Donald S. Kaufman, Niall M. Heney, Daphne Y. Spiegel, Jason A. Efstathiou, Anthony L. Zietman, William U. Shipley> ;International Journal of Radiation Oncology, Biology, Physics. 2013 Jun 1
• 10 citations
  Trimodality Therapy for Bladder Conservation in Treatment of Invasive Bladder Cancer
  Timur Mitin, William U. Shipley, Jason A. Efstathiou, Niall M. Heney, Donald S. Kaufman, Richard T. Lee, Anthony L. Zietman> ;Current Urology Reports. 2013 Jan 23
• 293 citations
  Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience
  Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, Niall M. Heney, Donald S. Kaufman, Andrzej Niemierko, John J. Coen, Rafi Y. Skowronski, Jonathan J. Paly, F...> ;European Urology. 2012 Apr 1
• Long-term outcomes in patients with muscle-invasive bladder cancer after bladder-preserving combined-modality therapy: A pooled analysis of RTOG 8802, 8903, 9506, 9706...
  Mak RH, Hunt D, Shipley WU, Efstathiou JA, Tester WJ, Hagan MP, Kaufman DS, Heney NM, Zietman AL> ;J. Clin. Oncol.. 2012-02-10
• 63 citations
  Complications and Long-Term Results of Salvage Cystectomy After Failed Bladder Sparing Therapy for Muscle Invasive Bladder Cancer
  Jairam R. Eswara, Jason A. Efstathiou, Niall M. Heney, Jonathan J. Paly, Donald S. Kaufman, W. Scott McDougal, Francis J. McGovern, William U. Shipley> ;The Journal of Urology. 2012 Feb 1
• Initial report of RTOG 9601, a phase III trial in prostate cancer: Effect of anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) on f...
  Shipley WU, Hunt D, Lukka HR, Major P, Heney NM, Grignon D, Patel M, Bahary J, Lawton CA, Sandler HM> ;J. Clin. Oncol.. 2011-03-01
• 140 citations
  Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06
  Jason A. Efstathiou, Kyounghwa Bae, William U. Shipley, Donald S. Kaufman, Michael P. Hagan, Niall M. Heney, Howard M. Sandler> ;Journal of Clinical Oncology. 2009 Sep 1
• 13 citations
  The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystecto...
  Jennifer Y. Wo, William U. Shipley, Douglas M. Dahl, John J. Coen, Niall M. Heney, Donald S. Kaufman, Anthony L. Zietman> ;BJU International. 2009 Jul 1
• 130 citations
  Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy fol...
  Donald S. Kaufman, Kathryn Winter, William U. Shipley, Niall M. Heney, H. James Wallace, Leonard M. Toonkel, Anthony L. Zietman, Simon Tanguay, Howard M. Sandler> ;Urology. 2009 Apr 1
• 2 citations
  Surgery: selective bladder-preserving therapy for muscle-invasive cancer.
  Niall M. Heney, Donald S. Kaufman, William U. Shipley> ;Nature Reviews. Clinical Oncology. 2009 Apr 1
• 28 citations
  Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
  Raymond H. Mak, Anthony L. Zietman, Niall M. Heney, Donald S. Kaufman, William U. Shipley> ;BJU International. 2008 Nov 1
• 17 citations
  Bladder-sparing approaches to invasive disease
  Jason A. Efstathiou, Anthony L. Zietman, Donald S. Kaufman, Niall M. Heney, John J. Coen, William U. Shipley> ;World Journal of Urology. 2006 Nov 3
• 111 citations
  Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with mu...
  Arnab Chakravarti, Kathryn Winter, Chin-Lee Wu, Donald S. Kaufman, Elizabeth Hammond, Matthew Parliament, William Tester, Michael P. Hagan, David J. Grignon, Niall M. ...> ;International Journal of Radiation Oncology, Biology, Physics. 2005 Jun 1
• 24 citations
  Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder.
  M.D. Michaelson, William U. Shipley, Niall M. Heney, Anthony L. Zietman, Donald S. Kaufman> ;British Journal of Cancer. 2004 Feb 9
• 6 citations
  Case 39-2003
  Niall M. Heney, Robert H. Young> ;The New England Journal of Medicine. 2003 Dec 18
• 237 citations
  Selective bladder preservation by combined modality protocol treatment: Long-term outcomes of 190 patients with invasive bladder cancer
  William U. Shipley, Donald S. Kaufman, E Zehr, Niall M. Heney, S.C. Lane, H.K Thakral, Alex F. Althausen, Anthony L. Zietman> ;Urology. 2002 Jul 1
• Join now to see all